- Systems
- Consumables
- Point-of-Care Testing Devices
Europe Hemostasis Diagnostics Market size values USD XX billion in 2022 and expected to reach USD XX billion in 2028 at a CAGR of X% from 2023-2029. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. Increase in the prevalence of hemostasis related disease in Europe countries (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), rise in number of surgery cases, rise in R&D investment for novel tests and devices innovation, and well developed healthcare infrastructure are expected to boost the hemostasis diagnostics market. However, high cost of advanced hemostasis products, and stringent regulations for the test approvals are expected to hamper the growth of hemostasis diagnostics market. This market research report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.
Europe Hemostasis Diagnostics Market Dynamics
ncrease in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.
Europe Hemostasis Diagnostics Market Country Analysis
Geographically, Europe hemostasis diagnosis market is segmented into U.K., France, Germany, Russia, Spain, Italy, Poland, and Rest of Europe. U.K. hemostasis diagnostics market accounted for significant share, which is attributed to rise in prevalence of hemophilia (according to World Federation of Hemophilia Global Survey 2010, approximately 6,573 people are suffering from hemophilia), increase in prevalence of cardiovascular diseases, and adoption of newer technologies are expected to propel the market in U.K. France hemostasis diagnostics market is growing due to rise in funding for launching test kits. For instance, in March 2016, Emosis, a French company raised 1 Mn Euros funding from Cap Innov for the development of hemostasis test kits. Germany hemostasis market growth driven by increase in the R&D for innovation of newer products, rise in prevalence of hemophilia disease, and expansion of business by market players in the country. Russia hemostasis diagnostics market is rising due to organization of training programs for doctors on coagulation testing by market players.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The europe hemostasis diagnostics market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Europe Hemostasis Diagnostics Market Segmentation
By Product Type
By Test Type
- Fibrinogen Test
- Activated Clotting Time
- Platelet Function
- Prothrombin Time
- Heparin & Protamine Dose-Response Test For ACT
- Activated Partial Thromboplastin Time
- Anti-Factor Xa
- Other Coagulation Tests
By Technology
- Optical
- Mechanical
- Electrochemical
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Centres
- Others (POC)
Frequently Asked Questions
2022 is the base year and 2029 is the forecast year.
The report covers the countries market data: Germany, France, Italy, Spain, and United Kingdom (UK)
Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Alere Inc., Nihon Kohden Corporation
| 1.Executive Summary |
| 2. Europe Hemostasis Diagnostics Market Introduction |
| 2.1. Europe Hemostasis Diagnostics Market - Taxonomy |
| 2.2. Europe Hemostasis Diagnostics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Test Type |
| 2.2.3.Technology |
| 2.2.4.End User |
| 2.2.5.Country |
| 3. Europe Hemostasis Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Hemostasis Diagnostics Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Hemostasis Diagnostics Market By Product Type , 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 5.1. Systems |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Point-of-Care Testing Devices |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Europe Hemostasis Diagnostics Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 6.1. Fibrinogen Test |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Activated Clotting Time |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Platelet Function |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Prothrombin Time |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Heparin & Protamine Dose-Response Test For ACT |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Activated Partial Thromboplastin Time |
| 6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Anti-Factor Xa |
| 6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Other Coagulation Tests |
| 6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7. Europe Hemostasis Diagnostics Market By Technology, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 7.1. Optical |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Mechanical |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Electrochemical |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Europe Hemostasis Diagnostics Market By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 8.1. Hospitals |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Clinics |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Diagnostic Centres |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Others (POC) |
| 8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 9. Europe Hemostasis Diagnostics Market By Country, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 9.1. Germany |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. France |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Italy |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. United Kingdom (UK) |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Spain |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Rest of EU |
| 9.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
| 9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.6.3. Market Opportunity Analysis |
| 10.Germany Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems |
| 10.1.2.Consumables |
| 10.1.3.Point-of-Care Testing Devices |
| 10.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fibrinogen Test |
| 10.2.2.Activated Clotting Time |
| 10.2.3.Platelet Function |
| 10.2.4.Prothrombin Time |
| 10.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 10.2.6.Activated Partial Thromboplastin Time |
| 10.2.7.Anti-Factor Xa |
| 10.2.8.Other Coagulation Tests |
| 10.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical |
| 10.3.2.Mechanical |
| 10.3.3.Electrochemical |
| 10.3.4.Others |
| 10.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Hospitals |
| 10.4.2.Clinics |
| 10.4.3.Diagnostic Centres |
| 10.4.4.Others (POC) |
| 11.France Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems |
| 11.1.2.Consumables |
| 11.1.3.Point-of-Care Testing Devices |
| 11.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fibrinogen Test |
| 11.2.2.Activated Clotting Time |
| 11.2.3.Platelet Function |
| 11.2.4.Prothrombin Time |
| 11.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 11.2.6.Activated Partial Thromboplastin Time |
| 11.2.7.Anti-Factor Xa |
| 11.2.8.Other Coagulation Tests |
| 11.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical |
| 11.3.2.Mechanical |
| 11.3.3.Electrochemical |
| 11.3.4.Others |
| 11.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Hospitals |
| 11.4.2.Clinics |
| 11.4.3.Diagnostic Centres |
| 11.4.4.Others (POC) |
| 12.Italy Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Systems |
| 12.1.2.Consumables |
| 12.1.3.Point-of-Care Testing Devices |
| 12.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Fibrinogen Test |
| 12.2.2.Activated Clotting Time |
| 12.2.3.Platelet Function |
| 12.2.4.Prothrombin Time |
| 12.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 12.2.6.Activated Partial Thromboplastin Time |
| 12.2.7.Anti-Factor Xa |
| 12.2.8.Other Coagulation Tests |
| 12.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Optical |
| 12.3.2.Mechanical |
| 12.3.3.Electrochemical |
| 12.3.4.Others |
| 12.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Hospitals |
| 12.4.2.Clinics |
| 12.4.3.Diagnostic Centres |
| 12.4.4.Others (POC) |
| 13.United Kingdom (UK) Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Systems |
| 13.1.2.Consumables |
| 13.1.3.Point-of-Care Testing Devices |
| 13.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Fibrinogen Test |
| 13.2.2.Activated Clotting Time |
| 13.2.3.Platelet Function |
| 13.2.4.Prothrombin Time |
| 13.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 13.2.6.Activated Partial Thromboplastin Time |
| 13.2.7.Anti-Factor Xa |
| 13.2.8.Other Coagulation Tests |
| 13.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Optical |
| 13.3.2.Mechanical |
| 13.3.3.Electrochemical |
| 13.3.4.Others |
| 13.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Hospitals |
| 13.4.2.Clinics |
| 13.4.3.Diagnostic Centres |
| 13.4.4.Others (POC) |
| 14.Spain Hemostasis Diagnostics Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
| 14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Systems |
| 14.1.2.Consumables |
| 14.1.3.Point-of-Care Testing Devices |
| 14.2. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Fibrinogen Test |
| 14.2.2.Activated Clotting Time |
| 14.2.3.Platelet Function |
| 14.2.4.Prothrombin Time |
| 14.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 14.2.6.Activated Partial Thromboplastin Time |
| 14.2.7.Anti-Factor Xa |
| 14.2.8.Other Coagulation Tests |
| 14.3. Technology Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Optical |
| 14.3.2.Mechanical |
| 14.3.3.Electrochemical |
| 14.3.4.Others |
| 14.4. End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Hospitals |
| 14.4.2.Clinics |
| 14.4.3.Diagnostic Centres |
| 14.4.4.Others (POC) |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Hoffmann-La Roche Ltd. |
| 15.2.2.Sysmex Corporation |
| 15.2.3.Abbott Laboratories |
| 15.2.4.Alere Inc. |
| 15.2.5.Nihon Kohden Corporation |
| 15.2.6.Siemens Healthineers |
| 15.2.7.Danaher Corporation |
| 15.2.8.Instrumentation Laboratory |
| 15.2.9.Grifols S.A |
| 15.2.10.Beckman Coulter, Inc. |
| 15.2.11.Emosis Diagnostics |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
- Hoffmann-La Roche Ltd.
- Sysmex Corporation
- Abbott Laboratories
- Alere Inc.
- Nihon Kohden Corporation
- Siemens Healthineers
- Danaher Corporation
- Instrumentation Laboratory
- Grifols S.A
- Beckman Coulter, Inc.
- Emosis Diagnostics